ライフサイエンスコーパス: grade

1 was followed by clonal expansion and recurrence at a higher grade.

2 In grade 1 HE the S-ANT1 was lower than in MHE.

3 Treatment-related adverse events were generally grade 1 or 2 in severity.

4 23.3%) of 103 recipients were diagnosed with PAT (including grade 1).

5 with multiple organ failure (acute-on-chronic liver failure grade 2-3).

6 The most frequently observed grade 3 and 4 adverse events were transaminase increases (40%

7 Other grade 3 disorders included hepatobiliary and renal disorders

8 dverse events (myositis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis

9 Fifty-five percent of patients had grade 3 or 4 neurologic toxicities that completely resolved.

10 Adverse events of grade 3 or higher were reported in 87% of the patients in the

11 itis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis).

12 IMRT was associated with less >/= grade 3 pneumonitis (7.9% v 3.5%, P = .039) and a reduced ris

13 m treatment-related adverse events (myositis in addition to grade 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, an

14 e most frequently skin related, GI, endocrine, and hepatic; grade 3 to 4 select AEs occurred in 4% of patients.

15 New albumin, bilirubin, and alkaline phosphatase grade 3/4 toxicities were, respectively, 3%, 10%, and 0% for

16 de 3 thyroiditis, grade 3 hepatitis, grade 3 pneumonia, and grade 4 myocarditis).

17 Grade 4 toxicity occurred in 32%, and 5% had treatment-associ

18 in adolescents (per 100-g increase in birth weight, -0.004 grade, 95% CI: -0.04, 0.04) using instrumental variable analy

19 l regression gave a small positive association (0.02 higher grade, 95% CI: 0.01, 0.03).

20 High-quality (grade A) TR Doppler was present in 68% at rest and 34% at pea

21 es and positively correlated with cell proliferation, tumor grade and malignancy.

22 these metagenes also have predictive value regarding tumor grade and patient outcomes.

23 tic patients (P=0.021 and P=0.05, respectively), whereas CE grade and the presence of neovessels were not.

24 ificant PF (International Study Group on Pancreatic Fistula Grade B or C) and hospital-related inpatient costs for 90 day

25 oma, BCL2 in follicular lymphoma, and MYC/BCL2/BCL6 in high-grade B-cell lymphomas are essential for diagnosis.

26 coding RNAs are observed in patients with asymptomatic high-grade carotid disease versus patients with acutely symptomati

27 Low-grade, chronic inflammation has been associated with many dis

28 ; 3.3 per 100 person-years among patients with baseline low-grade dysplasia (95% CI 1.5-7.2), and 7.3 per 100 person-year

29 7.3 per 100 person-years among patients with baseline high-grade dysplasia (95% CI 4.2-12.5).

30 sies was 13% (5-27), whereas the probability of having high-grade dysplasia or intramucosal adenocarcinoma was 87% (73-95

31 Vs were compared with prognostic factors such as histologic grade (G1, G2, or G3, for low-grade [well differentiated], in

32 enetic alterations observed during the development of lower-grade glioma (LGG).

33 ions by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and

34 ade ( P = .02), with an increased risk for low-intermediate grade (HR, 1.14; 95% CI, 1.01 to 1.29) but not high-grade pro

35 al needs when Class II or III furcation involvements and/or Grade II or III tooth mobility were also detected in the sext

36 t 1 complication, and 26.9% experienced major morbidity (>/=grade III), mostly related to pulmonary complications (25.7%)

37 Thus, microglia and low-grade inflammation of myelinated tracts emerged as the trigge

38 Chronic low-grade inflammation, a hallmark of obesity, involves immune ce

39 pillary mucinous neoplasms (IPMN), 2 adenocarcinomas, 1 low-grade intraepithelial pancreatic neoplasia, and 1 case of pol

40 tive (6OTD), limits the growth of intractable glioblastoma (grade IV glioma) and glioma stem cells (GSCs).

41 bsequently, all cases of high-risk (hr) HPV-associated high-grade lesions and carcinomas in the anogenital region and oro

42 2, or G3, for low-grade [well differentiated], intermediate-grade [moderately differentiated], and high-grade [poorly dif

43 There was some evidence of heterogeneity by tumor grade ( P = .02), with an increased risk for low-intermediate

44 tudied by adding chlorogenic and rosmarinic acids, and food-grade phenolic apple and rosemary extracts at various dosages

45 ], intermediate-grade [moderately differentiated], and high-grade [poorly differentiated], respectively), chromogranin A,

46 Treatment-related adverse events (any grade) prompted treatment discontinuation in four (11%) patie

47 mediate grade (HR, 1.14; 95% CI, 1.01 to 1.29) but not high-grade prostate cancer (HR, 0.83; 95% CI, 0.64 to 1.07).

48 pecially relate to optimal field and transformation to high-grade radiation-associated sarcomas.

49 findings, but this proportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (18%-2

50 ic factors such as histologic grade (G1, G2, or G3, for low-grade [well differentiated], intermediate-grade [moderately d